RNA polymerase inhibitor enisamium for treatment of moderate COVID-19 patients: a randomized, placebo-controlled, multicenter, double-blind phase 3 clinical trial

Olha Holubovska; Pavlo Babich; Alla Mironenko; Jens Milde; Yuriy Lebed; Holger Stammer; Lutz Mueller; Aartjan J.W. te Velthuis; V. Margitich; Andrew Goy

bioRxiv (2022) - Comments
doi: 10.1101/2022.08.21.22279036

Olha Holubovska, Pavlo Babich, Alla Mironenko, Jens Milde, Yuriy Lebed, Holger Stammer, Lutz Mueller, Aartjan J.W. Te Velthuis, V. Margitich, Andrew Goy